510(k) Report

510(k) · Cleared

Cleared

Gold Anchor

K213053510(k) TraditionalCleared Jan 6, 2022106-day reviewClass II21 CFR 892.5050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Naslund Medical AB · IYE Accelerator, Linear, Medical

Cleared on Jan 6, 2022 as substantially equivalent to K201117 (Naslund Medical AB, 2020) after a 106-day review. Its family tree reaches back 9 generations to 1987.

Decided
Jan 6, 2022
Review
106 days
Class
Class II
Product code
IYE
Recalls
None
Predicates
1

Its longest line of descent runs back 9 generations to K874787 (1987). 14 ancestors in all. No later device cites it as a predicate yet.

  1. Root · 9 generations backK874787 Modified Palladium Seed Model 100Theragenics Corp. · 1987
  2. 5 generations between
  3. 3 generations backK091645 Gold AnchorNaslund Medical AB · 2009
  4. 2 generations backK160209 Gold AnchorNaslund Medical AB · 2016
  5. 1 generation backK201117 Gold AnchorNaslund Medical AB · 2020
  6. This deviceK213053 Gold AnchorNaslund Medical AB · 2022
Show all 9 generations
  1. Root · 9 generations backK874787 Modified Palladium Seed Model 100Theragenics Corp. · 1987
  2. 8 generations backK001070 Radiomed SourceRadiomed Corp. · 2000
  3. 7 generations backK013660 GenetraRadiomed Corporation · 2001
  4. 6 generations backK022326 Radiomed MarkerRadiomed Corporation · 2003
  5. 5 generations backK031206 Radiomed Soft Tissue MarkerRadiomed Corp. · 2003
  6. 4 generations backK070305 Pre-Loaded VisicoilRadiomed Corporation · 2007
  7. 3 generations backK091645 Gold AnchorNaslund Medical AB · 2009
  8. 2 generations backK160209 Gold AnchorNaslund Medical AB · 2016
  9. 1 generation backK201117 Gold AnchorNaslund Medical AB · 2020
  10. This deviceK213053 Gold AnchorNaslund Medical AB · 2022
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−9K874787Modified Palladium Seed Model 100Theragenics Corp.1987—
−8K001070Radiomed SourceRadiomed Corp.2000—
−7K013660GenetraRadiomed Corporation2001—
−6K022326Radiomed MarkerRadiomed Corporation2003—
−5K031206Radiomed Soft Tissue MarkerRadiomed Corp.2003—
−4K070305Pre-Loaded VisicoilRadiomed Corporation2007—
−3K091645Gold AnchorNaslund Medical AB2009—
−2K160209Gold AnchorNaslund Medical AB2016—
−1K201117Gold AnchorNaslund Medical AB2020—
0 (this device)K213053Gold AnchorNaslund Medical AB2022—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199420
199710
199910
200010
FIG. 1 — Lineage of K213053, 1987–2022Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in IYE? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new IYE device

  1. #1 K252977 Halcyon, Ethos Radiotherapy System (5.0)score 18.8 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K201117Gold Anchor
Summary page 4
…Accelerator, Linear, Medical Regulatory Class: II Product Code: IYE III. PREDICATE DEVICE Predicate device: Gold Anchor, K201117 IV. DEVICE DESCRIPTION The Gold Anchor marker is a fiducial gold marker intended to be implanted within the body, either tempora…
Naslund Medical AB2020—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 35 years and passes through 4 companies; a new generation was cleared every 2.4 years on median.
  • None of the 14 ancestors has a recall.

How does its category compare?

All IYE devices

IYE Accelerator, Linear, Medical: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · IYE

12in 2025

2007: 232008: 142009: 202010: 232011: 112012: 282013: 182014: 202015: 202016: 212017: 232018: 212019: 192020: 202021: 192022: 122023: 182024: 92025: 122026 (partial year): 14
2007high 28 (2012) · low 9 (2024)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · IYE

170in 2025

2007: 44 days median2008: 69 days median2009: 63 days median2010: 74 days median2011: 94 days median2012: 106 days median2013: 88 days median2014: 100 days median2015: 108 days median2016: 97 days median2017: 94 days median2018: 58 days median2019: 83 days median2020: 67 days median2021: 86 days median2022: 172 days median2023: 129 days median2024: 239 days median2025: 170 days median2026 (partial year): 120 days median
2007high 239 (2024) · low 44 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · IYE

1in 2025

2007: 782008: 492009: 222010: 272011: 732012: 202013: 112014: 142015: 82016: 72017: 72018: 72019: 22020: 42021: 52022: 32023: 72024: 12025: 12026 (partial year): 4
2007high 78 (2007) · low 1 (2024)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · IYE

101in 2025

2007: 1552008: 1142009: 1742010: 2462011: 2802012: 1282013: 962014: 1242015: 1002016: 972017: 1252018: 852019: 912020: 742021: 682022: 662023: 1282024: 812025: 101
2007high 280 (2011) · low 66 (2022)2025

MAUDE reports naming product code IYE, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007234478155
2008146949114
2009206322174
2010237427246
2011119473280
20122810620128
201318881196
20142010014124
2015201088100
20162197797
201723947125
20182158785
20191983291
20202067474
20211986568
202212172366
2023181297128
20249239181
2025121701101
2026141204—

What is it indicated for?

The Gold Anchor marker is indicated for use to radiographically mark soft tissue for future therapeutic procedures.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K213053: Gold Anchor.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213053

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026